US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist

1.170
+0.270+30.00%

Close Nov 25 16:00 ET

1.210
+0.040+3.42%

Post 17:58 ET

2.18MMarket Cap-605P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

60 Degrees Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 300.000K	--
--	2024/Q4	-- / 234.000K	--
--	2024/Q3	135.290K / 242.000K	--
--	2024/Q2	124.970K / 211.500K	--
--	2024/Q1	116.460K / 150.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 300.000K--

--2024/Q4-- / 234.000K--

--2024/Q3135.290K / 242.000K--

--2024/Q2124.970K / 211.500K--

--2024/Q1116.460K / 150.000K--

Unlock Free Earnings Estimates

Open Account

60 Degrees Pharmaceuticals Earnings Reports

10-Q: Q3 2024 Earnings Report

Nov 14 13:48 ET

10-Q: Q2 2024 Earnings Report

Aug 14 10:34 ET

10-Q: Q1 2024 Earnings Report

May 15 12:00 ET

60 Degrees Pharmaceuticals | 10-K: FY2023 Annual Report

Apr 1 14:37 ET

Analyst Rating

Updated: Nov 19, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall